​

Funding Round

Post-IPO Debt - Oncorus

Post-IPO Debt - Oncorus

Investment Firm

Overview

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Announced Date

Apr 05, 2022

Funding Type

Post Ipo Debt

Highlights

Location

United States, North America

Social

Investor Lead

K2 HealthVentures

K2 HealthVentures

K2 HealthVentures is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorK2 HealthVentures

Round Details and Background

Oncorus raised $20000000 on 2022-04-05 in Post-IPO Debt

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 12, 2021
Post-IPO Equity - Oncorus
-57.0M
Apr 05, 2022
Post-IPO Debt - Oncorus
1-20.0M
Dec 16, 2016
Series A - Oncorus
1-5.0M
Jul 19, 2016
Series A - Oncorus
7-57.0M

Recent Activity

There is no recent news or activity for this profile.